Exeantide in Type 2 Diabetes on Insulin

Clinical trial NCT01154933 · COMPLETED

Trial details

NCT number: NCT01154933
Sponsor: University at Buffalo
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2008-04-01
Primary completion: 2011-11-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.